Privi shareholders approve merger of two private companies

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹3372.20

prior close

₹3538.50

announcement price

In-mkt

timing

Nifty Smallcap 250market+2.2%+2.8% vs market

Specialty Chemicals peers, median of 100sector+1.6%+3.4% vs sector

On the reaction day the stock moved 2.8 pts more than Nifty Smallcap 250 and 3.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.4

15m

-0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+2.2+2.8+1.6+3.4

Next day

+3.0pendingpending+1.9+1.2

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On October 27, 2026, 57 equity shareholders approved the amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with listed Privi Speciality Chemicals Limited by the required majority. The meeting followed a September 7 National Company Law Tribunal order. Results will be declared separately.

Likely market impact

Shareholder approval is a positive milestone, but final effectiveness and financial benefits are not yet confirmed in this filing.